These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7447430)

  • 1. Comparative antimicrobial activity of O-demethylfortimicin A, a derivative of fortimicin A.
    Girolami RL; Stamm JM
    Antimicrob Agents Chemother; 1980 Nov; 18(5):766-72. PubMed ID: 7447430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fortimicins A and B, new aminoglycoside antibiotics. IV. In vitro study of fortimicin A compared with other aminoglycosides.
    Girolami RL; Stamm JM
    J Antibiot (Tokyo); 1977 Jul; 30(7):564-70. PubMed ID: 19409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compound A49759, the 3-O-demethyl derivative of fortimicin A: in vitro comparison with six other aminoglycoside antibiotics.
    Jones RN; Thornsberry C; Barry AL; Packer RR; Baker CN; Badal RE
    Antimicrob Agents Chemother; 1980 Nov; 18(5):773-9. PubMed ID: 7447431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and bacteriological study of O-demethylfortimicin A sulfate in urinary infection].
    Serieys C; Bergogne-Bérézin E; Prokocimer P; Delcercq D
    Pathol Biol (Paris); 1986 May; 34(5):490-3. PubMed ID: 3534728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro evaluation of tobramycin, a new aminoglycoside antibiotic.
    Levison ME; Knight R; Kaye D
    Antimicrob Agents Chemother; 1972 May; 1(5):381-4. PubMed ID: 4670478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-N HAPA gentamicin B, a new aminoglycoside active against gentamicin resistant isolates--activity compared to other aminoglycosides.
    Neu HC; Fu KP
    J Antibiot (Tokyo); 1978 May; 31(5):385-93. PubMed ID: 27494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in-vitro activity of O-demethylfortimicin.
    Neu HC
    J Antimicrob Chemother; 1983 Feb; 11(2):181-5. PubMed ID: 6833173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial activity of fortimicin A compared with those of five other aminoglycosides, and factors affecting susceptibility tests.
    Thornsberry C; Barry AL; Jones RN; Baker CN; Badal RE; Packer RR
    Antimicrob Agents Chemother; 1981 Jan; 19(1):122-9. PubMed ID: 7247351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piperacillin (T-1220), a new semisynthetic penicillin. II. In vitro antimicrobial activity and synergy comparison with carbenicillin and gentamicin.
    Jones RN; Packer RR; Barry AL; Badal RE; Thornsberry C; Baker C
    J Antibiot (Tokyo); 1979 Jan; 32(1):29-35. PubMed ID: 761991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic activities of fortimicin A and beta-lactam antibiotics against Pseudomonas aeruginosa.
    Yamashita K; Kawabe H; Mitsuhashi S
    Antimicrob Agents Chemother; 1981 Jul; 20(1):33-7. PubMed ID: 6792980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative in vitro activity of LY 127935 (6059-S), seven cephalosporins, three aminoglycosides, carbenicillin, and ticarcillin.
    Watanakunakorn C; Glotzbecker C
    J Antibiot (Tokyo); 1979 Oct; 32(10):1019-24. PubMed ID: 528361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
    Giamarellou H
    Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of netilmicin, gentamicin, and amikacin.
    Kantor RJ; Norden CW
    Antimicrob Agents Chemother; 1977 Jan; 11(1):126-31. PubMed ID: 402104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergy of azlocillin and mezlocillin combined with aminoglycoside antibiotics and cephalosporins.
    Neu HC; Fu KP
    Antimicrob Agents Chemother; 1978 May; 13(5):813-9. PubMed ID: 666302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fortimicin A: collaborative in vitro susceptibility. Comparison with amikacin and gentamicin against 11,840 clinical bacterial isolates.
    Jones RN; Barry AL; Fuchs PC; Gavan TL; Sommers HM; Gerlach EH
    Antimicrob Agents Chemother; 1979 Dec; 16(6):823-8. PubMed ID: 533262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tobramycin: a review of its antibacterial and pharmacokinetic properties and therapeutic use.
    Brogden RN; Pinder RM; Sawyer PR; Speight TM; Avery GS
    Drugs; 1976; 12(3):166-200. PubMed ID: 789045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of 5-episisomicin compared with that of other aminoglycosides.
    Fu KP; Neu HC
    Antimicrob Agents Chemother; 1978 Aug; 14(2):194-200. PubMed ID: 697347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vitro appraisal of piperacillin, including its activity against Salmonella typhi.
    Robinson RG; Saunders J; Cassel R; Block CS; Koornhof HJ
    Antimicrob Agents Chemother; 1980 Oct; 18(4):493-501. PubMed ID: 6449903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial effectiveness ofkanamycin, aminosidin, BB-K8, sisomicin, gentamicin and tobramycin combined with carbenicillin or cephalothin against gram-negative rods.
    Klastersky J; Nyamubeya B; Vandenborre L
    J Med Microbiol; 1974 Nov; 7(4):465-72. PubMed ID: 4217836
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative study of the antibacterial activity of aminoglycoside antibiotics and their combinations with carbenicillin against Pseudomonas aeruginosa].
    Iakushkina IV; Shapovalova SP; Malkova IV
    Antibiotiki; 1982 Aug; 27(8):601-7. PubMed ID: 6812489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.